Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketadex dose-comparison study for sedation and analgesia in healthy adults
ACTRN12620000117910Phase 2Recruiting
- Sponsor
- Monash Medical Centre
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Ketadex, dexmedetomidine and ketamine in pain, sponsored by Monash Medical Centre. Primary endpoint: Sedation. Started Mar 2020; status: recruiting.
02
Drugs
Ketadexdexmedetomidineketamine
03
Conditions
pain
Beyond the preview
Go deeper on ACTRN12620000117910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000117910.